Director, Customer Experience- Neuroscience at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Neuroscience, HealthcareIndustries

Requirements

Advanced scientific degree and/or preferred
Minimum 8 years of pharmaceutical or biotechnology experience
A minimum of three years marketing and/or customer experience with consumer marketing and/or patient services experience preferred
Cross-functional experience in pharmaceutical or biotechnology field (i.e. field sales, training, analytics)
Neuropsychiatry experience is preferred
Customer-facing experience is preferred
Demonstrated ability to work effectively cross-functionally with a positive team mindset and can-do attitude
Customer/commercial mindset
Demonstrated ability to drive business results
Collaboration and teaming across a broad spectrum of internal and external partners
Experience identifying, engaging, and cultivating credibility with customers across the patient care journey
Demonstrates learning agility and ability to develop and optimize new solutions
Understands the patient journey and experience
Has a patient-focused mindset
Ability to analyze data, such as prescribing patterns, market trends, and patient preferences
Demonstrated track record of developing and managing an operating budget
Strong business acumen to understand and analyze business and market drivers and develop, execute, and adjust business plans

Responsibilities

Insight Generation: Collaborate with Business Insights & Analytics to conduct market research and external benchmarking
Insight Generation: Engage externally with provider and patient groups to learn about their needs and pressure-test ideas to inform expanded and new engagement and enrollment channels
Strategy: Lead and implement a comprehensive Customer Experience Engagement Strategy
Content Development: Develop approved programs and materials to educate on Customer Experience offerings
External Engagement: Engage externally to form and implement novel strategic alliances and external collaborations that deliver intended results

Skills

Customer Experience Strategy

Stakeholder Education

HCP Engagement

Patient Engagement

Tech Solutions

Cross-Functional Collaboration

Marketing

Market Access

Advocacy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free